Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Intangibles (2016 - 2025)

Historic Intangibles for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $75.6 million.

  • Orthofix Medical's Intangibles fell 2764.81% to $75.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.6 million, marking a year-over-year decrease of 2764.81%. This contributed to the annual value of $98.8 million for FY2024, which is 5424.3% down from last year.
  • Latest data reveals that Orthofix Medical reported Intangibles of $75.6 million as of Q3 2025, which was down 2764.81% from $78.9 million recorded in Q2 2025.
  • Orthofix Medical's Intangibles' 5-year high stood at $215.9 million during Q4 2023, with a 5-year trough of $47.5 million in Q3 2022.
  • For the 5-year period, Orthofix Medical's Intangibles averaged around $95.4 million, with its median value being $98.8 million (2024).
  • Its Intangibles has fluctuated over the past 5 years, first soared by 15471.13% in 2023, then tumbled by 5424.3% in 2024.
  • Over the past 5 years, Orthofix Medical's Intangibles (Quarter) stood at $125.2 million in 2021, then fell by 0.3% to $124.8 million in 2022, then surged by 72.95% to $215.9 million in 2023, then tumbled by 54.24% to $98.8 million in 2024, then fell by 23.44% to $75.6 million in 2025.
  • Its Intangibles was $75.6 million in Q3 2025, compared to $78.9 million in Q2 2025 and $81.2 million in Q1 2025.